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Growth Hormone (GH), insulin-like
growth factor I (IGF-I), parathyroid hormone-
related protein (PTHTP) (1) and pyridinoline
are known to be involved in bone metabolism
in children. Recently, procollagen type 1 car-
boxy terminal propeptide (PICP) and type 1
collagen carboxy terminal telopeptide (ICTP)
have been recognized as the markers for bone
formation and resorption. Therefore in this
study, we investigated the correlation among
these parameters in normal children, and
investigated the physiological roles in bone
metabolism.
Subjects and Methods
The subjects in this study were 50 normal
children aged 3-15 years. Urine samples were
collected in the early morning and used for
measurements of GH, pyridinoline, PTHTP,
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calcium, phosphate and creatinine. Serum
levels of IGF-I, PICP and ICTP were also mea-
sured from samples obtained in the morning in
16 of these subjects. Assay kits were as fol-
lows: urinary GH, Picoia HGH plate,
Sumitomo Pharmaceutical Co., Ltd, Japan;
urinary pyridinoline, Metra Biosystems Inc.,
USA; urinary and serum PTHTP, Daiichi
Radioisotope, Japan; PICP and ICTP, Chugai
Pharmaceutical Co., Ltd., Japan.
Results and Discussion
Mean serum levels of these parameters
were as follows; Pyridinoline 173 + 74 nmoll
mmol cr, GH 23 + L5 pg/mg cr, PTHrP 3.0 + 1.4
nmol/mg cr, IGF-I 244 r78 r,g/mL, PICP 299
t 60 nglml, ICTP L2.7 t 4.L ng/mL. Correla-
tion among these parameters were
investigated and their P values were as fol-
lows;
Significant positive correlations were
observed between U-pyridinoline and U-
PTHrP (Fig. 1-a), U-pyridinoline and serum
IGF-I (Fig. 1-b), U-pyridinoline and ICTP (Fig.
1-c), and serum IGF-I and PICP (Fig. 1-d).
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Furthermore, a positive correlative tendency
was observed between GH and ICTP, between
PTHrP and PICP, and between PICP and ICTP
(P<0.10). However, urinary GH did not show
significant correlations, suggesting daily vari-
able data in urinary GH excretion.
Our results seem to be compatible with
previous reports, indicating PICP and IGF-I as
useful markers for bone formation, and ICTP
and urinary pyridinoline for bone resorption
(2, 3). In our former study (4), age-related
decline was found in urinary concentrations
of PTHrP (P>0.01), but not in those of GH,
cacium or phosphate. These results suggest an
elevated bone turnover rate in younger chil-
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Fig. I Correlation among urinary excretion of pyridinoline and PTHTP, and serum concentrations of IGF-
I, PICP and ICTP.
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dren. In this study, moderate age-related
decline was observed in U-pyridinoline, PICP
and ICTP. Further investigation would be nec-
cessary for making these parameters useful
markers in reflecting bone formation and
resorption in normal and diseased states in 3.
children.
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